Mostrando 9 resultados de: 9
Publisher
Electronic Journal of Biotechnology(2)
American Chemical Society, Polymer Preprints, Division of Polymer Chemistry(1)
BMC Cancer(1)
Biotechnology and Applied Biochemistry(1)
Biotecnologia Aplicada(1)
Área temáticas
Farmacología y terapéutica(7)
Enfermedades(4)
Biología(2)
Bioquímica(2)
Microorganismos, hongos y algas(2)
A synthetic conjugate polysaccharide vaccine against haemophilus influenzae type b
ArticleAbstract: Glycoconjugate vaccines provide effective prophylaxis against bacterial infections. To date, howeverPalabras claves:Autores:Aguilar A., Baly A., Campa C., Cardoso F., Carmenates A., Cosme K., Costa L., Deler M.L., Diaz M., Eugenio Hardy, Fernández-Santana V., Garcia E., Hernández I., Herrera L., Heynngnezz L., Izquierdo M., Medina E., Montane M., Muzachio A., Ramos A., Rodriguez A., Rodriguez M.C., Roy R., Sánchez R., Sosa I., Toledo-Romani M.E., Toraño G., Valdés Y., Verez-Bencomo V., Villar A.Fuentes:scopusCIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo
ArticleAbstract: Protein Kinase CK2 is a serine-threonine kinase frequently deregulated in many human tumors. Here, wPalabras claves:apoptosis, Cancer targeted therapy, Casein kinase 2Autores:Acevedo B.E., Alonso D.F., Ariosa J., Bacardí D.M., Baladron I., Besada-Pérez V., Betancourt L., Castellanos L.R., Cosme K., Cruz M., Díaz A., Falcón-Cama V., Farina H., Garay H.E., Gil J., Gómez D., Gómez R., González L.J., Hernández I., Herrera L., López C., López-Mola E., López-Saura P.A., Marcelo J.L., Mendoza O., Perea-Rodríguez S.E., Perera Y., Puchades Y., Reyes O., Rodriguez A., Sánchez A., Santana A., Serrano J.M., Sigman H., Silva R., Solares M., Thelvia I. Ramos Gómez, Valenzuela-Silva C.M.Fuentes:googlescopusDevelopment of semisolid preparations for topical delivery of epidermal growth factor
Conference ObjectAbstract: Epidermal growth factor (EGF) is an endogenous protein of 53 amino acids residues isolated from submPalabras claves:Autores:Aguilera A., Berlanga-Acosta J., Eugenio Hardy, Garcia O., Herrera L., Lazcano R.R., Lorenzo R.R., Ramos L.Fuentes:scopusExpression in Escherichia coli of the IpdA gene, protein sequence analysis and immunological characterization of the P64k protein from Neisseria meningitidis
ArticleAbstract: By making use of recombinant DNA technology it is possible to characterize meningococcal outer membrPalabras claves:Autores:Alvarez A., Besada-Pérez V., Caballero E., Carmenate T., Coizeau E., Estrada R., González L.J., González S., Guillén-Nieto G.E., Herrera L., Musacchio Lasa A., Nazabal C., Padrón G., Silva R., Támbara Y., Vivian Morera CórdovaFuentes:scopusIntramyocardial gene transfer of vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart
ArticleAbstract: Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen that is angiogenicPalabras claves:Collateral development, Coronary artery disease, Gene therapy, Naked plasmid DNA, revascularization, Therapeutic angiogenesisAutores:Alí A., Batista J.F., Chaos N., Coca M., Dominguez H., Garcia-Osuna T., González N., González R., Guevara L., Herrera L., Montequín J.F., Ojalvo A.G., Perera A., Puchades Y., Quián Y.P., Reima C., Reyes J.L., Santiago Nelson Vispo, Seralena A., Silva R., Vazquez R.Fuentes:scopusMolecular characterization of recombinant human interferon alpha-2b produced in Cuba
ArticleAbstract: The recombinant human interferon α 2b (IFN-γ(2b)) produced by Cuban technology is obtained from EschPalabras claves:IFN, Molecular characterization, Recombinant human interferon alfa 2bAutores:Beldarrain A., Besada-Pérez V., Betancourt L., Brito R., Curras T., Eugenio Hardy, Ferrero J., Gil M., González L.J., Herrera L., Huerta V., Martinez E., Moya G., Pujols V., Sanchez J.C., Santana-Milián H., Sosa R., Vivian Morera CórdovaFuentes:googlescopusOpen letter to president Biden about COVID vaccines for Cuba
OtherAbstract:Palabras claves:Autores:García D., Guillén-Nieto G.E., Herrera L., Lage Davila A., Mauri M., Pérez R., Tania Crombet, Valdés-Sosa M., Valdés-Sosa P., Vérez V.Fuentes:scopusSafety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies
ArticleAbstract: Background: Cervical cancer is now considered the second leading cause of death among women worldwidPalabras claves:Autores:Acevedo B.E., Alonso D.F., Baladron I., Castillo D., Díaz A., Gómez R., González C.A., Herrera L., López-Saura P.A., Perea-Rodríguez S.E., Santana A., Sigman H., Solares A.M., Thelvia I. Ramos Gómez, Valenzuela-Silva C.M.Fuentes:googlescopusTherapeutic angiogenesis following intramuscular gene transfer of vascularendothelial growth factor 121 in a dog model of hindlimb ischemia
ArticleAbstract: Vascular endothelial growth factor (VEGF), an endothelial cell-specific mitogen, has been shown to pPalabras claves:Collateral development, Gene therapy, Naked plasmid DNA, Peripheral vascular disease, revascularizationAutores:Aldama A., Alfonso M.A., Alí A., Herrera L., López-Saura P.A., Montequín J.F., Ojalvo A.G., Puchades Y., Santiago Nelson Vispo, Seralena A., Seuc A., Silva R., Simón R., Sorell L.T., Vazquez R.Fuentes:scopus